Latest Stock Market News

The operational performance across segments seems strong. The O2C plus oil and gas EBITDA is more than what the Street was working with. So, it is a better than expected result.

The bank reported a 31 per cent YoY drop in net interest income (NII) at Rs 1,764 crore from Rs 2,560 crore in the same quarter last year. Net interest margin (NIM) for the quarter came in at 2.4 per cent compared with 2.2 per cent in the September quarter and 3.4 per cent in the year-ago quarter.

Regional banks make a hefty chunk of their revenues from net interest margins, boosting their appeal as investors increasingly expect the Fed to hike interest rates more aggressively this year to control inflation. The central bank meets next week and is expected to raise interest rates as soon as March.

You might see some degree of bounce shaping up on the indices but that four days of selling which you have seen on the trot for the indices indicate that there could be more pain ahead in terms of individual stocks.

Drugmaker Biocon is banking on the ramp-up of interchangeable biosimilar insulin glargine expecting the product to boost the revenue and profit growth in the next several quarters, primarily from the US market.

The coming week is expected to see the levels of 17,750 and 17,800 acting as resistance points. The supports are likely to come in at 17,500 and 17,350 levels. The trading range is likely to get a bit narrower as compared to the previous week.

The auction route will be undertaken mainly to get improved offers so as to prevent the company from going into liquidation since the offers from all four bidders are below the liquidation value, they said. The Reliance Industries-Assets Care & Reconstruction Enterprise (ACRE) team, a Welspun entity, Himatsingka Ventures and GHCL have submitted resolution plans last month.

In the issue, 50% will be reserved for qualified institutional buyers (QIBs). Non-institutional buyers will have 15% of the share issue. The retail portion will get up to 35% of the offer.

The issue - the first IPO in 2022 - received applications for 22.35 crore shares against the 2.87 crore shares on offer.

​​Protection new business premium increased by 26 per cent from ₹1,620 crore in this fiscal so far to ₹2,040 crore.